M&A Deal Summary |
|
---|---|
Date | 2014-09-30 |
Target | The Laser Spine Institute |
Sector | Healthcare Services |
Buyer(s) | Sheridan Capital Partners |
Deal Type | Recapitalization |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 2012 |
PE ASSETS | 300M USD |
Size | Middle-Market |
Type | Sector Agnostic |
Sheridan Capital Partners is a private equity firm focused on acquiring and investing in consumer products/services and healthcare companies across the US and Canada. Sheridan looks to invest $15 to $100 million in businesses valued from $25 to $150 million. Prospective transaction situations include growth buyouts, family owned company acquisitions, consolidations, and recapitalizations. Sheridan Capital Partners was formed in 2012 and is headquartered in Chicago, Illinois.
DEAL STATS | # |
---|---|
Overall | 3 of 20 |
Sector (Healthcare Services) | 1 of 9 |
Type (Recapitalization) | 2 of 3 |
State (Florida) | 1 of 3 |
Country (United States) | 3 of 19 |
Year (2014) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2013-10-30 |
Progenicare
Austin, Texas, United States Progenicare is a provider of autologous stem cell therapies to orthopedic surgeons and hospitals across the Western U.S. Progenicare was founded in 2008 and is based in Austin, Texas. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2014-12-10 |
Diamondback Drugs
Scottsdale, Arizona, United States Diamondback Drugs LLC is a veterinary compounding pharmacy that distributes pharmaceutical products to individual pet owners, veterinary offices and clinics. The company's compounding facility allows Diamondback to provide a broad veterinary compounded pharmaceutical offering, ranging from anti-infectives and ophthalmic preparations to cancer treatment solutions. Diamondback has grown from a small veterinary compounder into a growing platform serving pets in 50 states, as well as Canada and Mexico. |
Sell | - |